 Home > Encyclopedia > 2-[3-[(1S,7S,13S,22S,25S,28S,35S)-35-amino-13,25-dibenzyl-2,8,11,14,17,23,26,29,36-nonaoxo-3,9,12,15,18,24,27,30,37-nonazatetracyclo[35.3.0.03,7.018,22]tetracontan-28-yl]propyl]guanidine

2-[3-[(1S,7S,13S,22S,25S,28S,35S)-35-amino-13,25-dibenzyl-2,8,11,14,17,23,26,29,36-nonaoxo-3,9,12,15,18,24,27,30,37-nonazatetracyclo[35.3.0.03,7.018,22]tetracontan-28-yl]propyl]guanidine

2-[3-[(1S,7S,13S,22S,25S,28S,35S)-35-amino-13,25-dibenzyl-2,8,11,14,17,23,26,29,36-nonaoxo-3,9,12,15,18,24,27,30,37-nonazatetracyclo[35.3.0.03,7.018,22]tetracontan-28-yl]propyl]guanidine structure

CAS No:
71685-02-4
Formula:
C49H69N13O9
Chemical Name:
2-[3-[(1S,7S,13S,22S,25S,28S,35S)-35-amino-13,25-dibenzyl-2,8,11,14,17,23,26,29,36-nonaoxo-3,9,12,15,18,24,27,30,37-nonazatetracyclo[35.3.0.03,7.018,22]tetracontan-28-yl]propyl]guanidine
Synonyms:
bradykinin, cyclo (N-(epsilon-1)-Lys(1)-Gly(6))-;bradykinin, cyclo (N-(epsilon-1)-lysyl(1)-glycine(6))-;CLGB;cyclo (N-(epsilon-1)-1-Lys-6-Gly)-bradykinin;CLGB;Bradykinin, cyclo (N-(epsilon-1)-lys(1)-gly(6))-;71685-02-4;Cyclo(N-(epsilon-1)-1-lys-6-gly)-bradykinin;Bradykinin, cyclo (N-(epsilon-1)-lysyl(1)-glycine(6))-;DTXSID40221914;Bradykinin, 1-L-lysine-6-glycine-, cyclic (9-1)-peptide;2-[3-[(1S,7S,13S,22S,25S,28S,35S)-35-amino-13,25-dibenzyl-2,8,11,14,17,23,26,29,36-nonaoxo-3,9,12,15,18,24,27,30,37-nonazatetracyclo[35.3.0.03,7.018,22]tetracontan-28-yl]propyl]guanidine

Request for Quotation

2-[3-[(1S,7S,13S,22S,25S,28S,35S)-35-amino-13,25-dibenzyl-2,8,11,14,17,23,26,29,36-nonaoxo-3,9,12,15,18,24,27,30,37-nonazatetracyclo[35.3.0.03,7.018,22]tetracontan-28-yl]propyl]guanidine Basic Attributes

Molecular Weight：

984.2 g/mol

Exact Mass：

983.53412083 g/mol

DSSTox ID：

DTXSID40221914

Characteristics

PSA：

326 Å²

Drug Information

MeSH Entry Terms：

bradykinin, cyclo (N-(epsilon-1)-Lys(1)-Gly(6))-

Computed Properties

Molecular Weight:984.2
XLogP3:-0.4
Hydrogen Bond Donor Count:9
Hydrogen Bond Acceptor Count:11
Rotatable Bond Count:8
Exact Mass:983.53412083
Monoisotopic Mass:983.53412083
Topological Polar Surface Area:326
Heavy Atom Count:71
Complexity:1920
Defined Atom Stereocenter Count:7
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Hot Searches: etoroxib; hexane 3 4 dione; jim tessa medication; acetic acid cost; piperazine; research chemical website

Guide of 2-[3-[(1S,7S,13S,22S,25S,28S,35S)-35-amino-13,25-dibenzyl-2,8,11,14,17,23,26,29,36-nonaoxo-3,9,12,15,18,24,27,30,37-nonazatetracyclo[35.3.0.03,7.018,22]tetracontan-28-yl]propyl]guanidine

Basic Attributes
Characteristics
Drug Information
Computed Properties

Request for Quotation



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.